4th International Pharmaceutical Conference and Expo welcome you as our guest to the City of London, UK during August 05-07, 2020. The theme of the upcoming edition of i- Pharma UK is Bridging Pharma Research with Industry.
The annual iPharma conference and expo 2020 is the largest gathering of Pharma and Healthcare professionals in the UK and in Europe. iPharma UK is expecting hundreds of academic, research and industry leaders from 24 different countries to gather in London, the UK for this three-day meeting.
i-Pharma Congress 2020 is packed with many workshops, symposiums and multiple plenary sessions with main focus on thought-provoking discussions and peer-led networking. The conference is the ideal venue to learn about the latest trends shaping the pharma industry, to gain new skills and insights from successful pharma experts.
For iPharma UK, 2020 renowned academic, researchers along with industry leaders from key pharma companies will be sharing their insights into the role of Drug Discovery, Drug Designing, Drug Development, Digital Pharma, Pharmacovigilance, Pharma Packaging, Biopharmaceuticals, Drug Delivery Systems and translating this into real-life strategies for your career and business.
iPharma UK 2020 offers unparalleled business, research opportunities and access to new markets in Pharma and Health Care industry. Be on the cutting edge of new and often yet-unreleased information and discover an area that piques your interest.
Join us and witness the booming industry by participating at iPharma 2020 UK and give your career and business access to new opportunities from throughout the world.
The pharmaceutical industry develops drugs to diagnose, cure, treat or prevent diseases. Pharmaceutical companies produce both generic and branded drugs. Pharmaceutical drugs are subjected to various laws and regulations that deal with patenting, testing, safety, efficacy, and marketing. Pharmaceutical drugs are intended for human or veterinary use presented in their finished dosage form. The global pharmaceuticals market was worth $934.8 billion in 2017 and will reach $1170 billion in 2021, growing at 5.8%, according to a recent pharma market research report by The Business Research Company. Healthcare as a whole is growing at over 7% year on year.